Evidence map›Paper›PMID 26019191›Full record

ArticleNeurology2015

Longitudinal patient-oriented outcomes in neuropathy: Importance of early detection and falls.

Brian Callaghan, Kevin Kerber, Kenneth M Langa, Mousumi Banerjee, Ann Rodgers, Ryan McCammon, James Burke, Eva Feldman

Abstract read
In one paragraph

Article in Neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. COVID-19 and the hidden threat of diabetic microvascular complications.Therapeutic advances in endocrinology and metabolism · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Review
  18. Article
  19. Diabetic neuropathy.Nature reviews. Disease primers · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Brian CallaghanFrom the University of Michigan (B.C., K.K., K.M.L., M.B., A.R., R.M., J.B., E.F.); and the VA Center for Clinical Management Research (K.M.L., J.B.), Ann Arbor, MI. bcallagh@med.umich.edu.
Kevin KerberFrom the University of Michigan (B.C., K.K., K.M.L., M.B., A.R., R.M., J.B., E.F.); and the VA Center for Clinical Management Research (K.M.L., J.B.), Ann Arbor, MI.
Kenneth M LangaFrom the University of Michigan (B.C., K.K., K.M.L., M.B., A.R., R.M., J.B., E.F.); and the VA Center for Clinical Management Research (K.M.L., J.B.), Ann Arbor, MI.
Mousumi BanerjeeFrom the University of Michigan (B.C., K.K., K.M.L., M.B., A.R., R.M., J.B., E.F.); and the VA Center for Clinical Management Research (K.M.L., J.B.), Ann Arbor, MI.
Ann RodgersFrom the University of Michigan (B.C., K.K., K.M.L., M.B., A.R., R.M., J.B., E.F.); and the VA Center for Clinical Management Research (K.M.L., J.B.), Ann Arbor, MI.
Ryan McCammonFrom the University of Michigan (B.C., K.K., K.M.L., M.B., A.R., R.M., J.B., E.F.); and the VA Center for Clinical Management Research (K.M.L., J.B.), Ann Arbor, MI.
James BurkeFrom the University of Michigan (B.C., K.K., K.M.L., M.B., A.R., R.M., J.B., E.F.); and the VA Center for Clinical Management Research (K.M.L., J.B.), Ann Arbor, MI.
Eva FeldmanFrom the University of Michigan (B.C., K.K., K.M.L., M.B., A.R., R.M., J.B., E.F.); and the VA Center for Clinical Management Research (K.M.L., J.B.), Ann Arbor, MI.

Funding

HRS Yrs29-34: Y33 SSA CoFundingU01AG009740 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jessica Faul, KENNETH M LANGA · 1990 to 2026
$555.8M
Research Education CoreP30AG024824 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Neil Alexander · 2004 to 2026
$29.2M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Implementation of Evidence-Based Practice for Benign Paroxysmal Positional VertigR01DC012760 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KERBER, KEVIN ANTHONY, MEURER, WILLIAM JOSEPH · 2013 to 2024
$6.2M
Tissue-Specific Metabolic Reprogramming in Diabetic ComplicationsDP3DK094292 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROSIUS, FRANK C, BURANT, CHARLES F · 2011 to 2011
$5.5M
The Cost of DementiaR01AG030155 · NIA · RAND CORPORATION · PI HURD, MICHAEL D · 2007 to 2011
$3.1M
Reducing Racial Disparities in Post-Stroke Disability in the ElderlyR01MD008879 · NIMHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BURKE, JAMES FRANCIS, SKOLARUS, LESLI ELIZABETH · 2014 to 2018
$1.9M
Solutions for Vertigo presentations in the Emergency Department (SOLVE) ProjectR18HS017690 · AHRQ · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KERBER, KEVIN ANTHONY · 2009 to 2012
$1.5M
Self-Diagnosis and Treatment Tools for Benign Paroxysmal Positional VertigoR18HS022258 · AHRQ · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KERBER, KEVIN ANTHONY · 2014 to 2018
$1.2M
Using Outcomes Analyses to Inform Implementation of NINDS Clinical TrialsK08NS082597 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BURKE, JAMES FRANCIS · 2013 to 2017
$948k
The Impact of the Metabolic Syndrome on NeuropathyK23NS079417 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CALLAGHAN, BRIAN CHRISTOPHER · 2013 to 2017
$939k
Dizziness in the Emergency Department: A Population-Based ProjectK23RR024009 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KERBER, KEVIN ANTHONY · 2007 to 2011
$797k
AHRQ HHS R18HS017690AHRQ HHS R18HS022258NCRR NIH HHS K23 RR024009NIA NIH HHS P30 AG024824NIA NIH HHS R01 AG030155NIA NIH HHS U01 AG009740NIA NIH HHS U01 AG09740NIDCD NIH HHS R01 DC012760NIDDK NIH HHS DP3DK094292NIDDK NIH HHS P30 DK020572NIMHD NIH HHS R01 MD008879NINDS NIH HHS K08 NS082597NINDS NIH HHS NS079417PHS HHS R24 082841
6 · The paper itself

Abstract

objectiveTo evaluate longitudinal patient-oriented outcomes in peripheral neuropathy over a 14-year time period including time before and after diagnosis.

methodsThe 1996-2007 Health and Retirement Study (HRS)-Medicare Claims linked database identified incident peripheral neuropathy cases (ICD-9 codes) in patients ≥65 years. Using detailed demographic information from the HRS and Medicare claims, a propensity score method identified a matched control group without neuropathy. Patient-oriented outcomes, with an emphasis on self-reported falls, pain, and self-rated health (HRS interview), were determined before and after neuropathy diagnosis. Generalized estimating equations were used to assess differences in longitudinal outcomes between cases and controls.

resultsWe identified 953 peripheral neuropathy cases and 953 propensity-matched controls. The mean (SD) age was 77.4 (6.7) years for cases, 76.9 (6.6) years for controls, and 42.1% had diabetes. Differences were detected in falls 3.0 years before neuropathy diagnosis (case vs control; 32% vs 25%, p = 0.008), 5.0 years for pain (36% vs 27%, p = 0.002), and 5.0 years for good to excellent self-rated health (61% vs 74%, p < 0.0001). Over time, the proportion of fallers increased more rapidly in neuropathy cases compared to controls (p = 0.002), but no differences in pain (p = 0.08) or self-rated health (p = 0.9) were observed.

conclusionsIn older persons, differences in falls, pain, and self-rated health can be detected 3-5 years prior to peripheral neuropathy diagnosis, but only falls deteriorates more rapidly over time in neuropathy cases compared to controls. Interventions to improve early peripheral neuropathy detection are needed, and future clinical trials should incorporate falls as a key patient-oriented outcome.

Indexed as

Accidental FallsAgedAged, 80 and overEarly DiagnosisFemaleHumansInternational Classification of DiseasesLongitudinal StudiesMaleMedicarePatient-Centered CarePeripheral Nervous System DiseasesTreatment OutcomeUnited States

Identifiers

PMID26019191
PMCPMC4501944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.